Paola Barbara Arimondo

Title: Paola Barbara Arimondo: Innovator in Pharmaceutical Chemistry

Introduction

Paola Barbara Arimondo is a prominent inventor based in Toulouse, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 4 patents to her name, her work focuses on innovative solutions for treating cancer and neurological diseases.

Latest Patents

Among her latest patents, Arimondo has developed "Hemi-synthetic trilobine analogs for use as a drug." This invention concerns a compound that serves as a DNMT inhibitor, which is particularly relevant in cancer treatment. Another notable patent is "Trilobine and its natural analogs for use as a drug," which highlights the use of trilobine and its bisbenzylisoquinoline alkaloidal analogues as DNMT inhibitors for treating cancer and neurological diseases, as well as for cell reprogramming.

Career Highlights

Throughout her career, Paola has worked with esteemed organizations such as Pierre Fabre Medicament and the Centre National De La Recherche Scientifique. Her experience in these institutions has allowed her to advance her research and contribute to significant medical innovations.

Collaborations

Paola has collaborated with notable colleagues, including Ludovic Halby and Yoann Menon, enhancing her research through teamwork and shared expertise.

Conclusion

Paola Barbara Arimondo's contributions to pharmaceutical chemistry exemplify her dedication to innovation in drug development. Her patents reflect her commitment to addressing critical health challenges, particularly in cancer treatment.